1. Belleville JP, Ward DS, Bloor BC, Maze M. 1992; Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 77:1125–33. DOI:
10.1097/00000542-199212000-00013. PMID:
1361310.
2. Ahuja V, Thapa D, Chander A, Gombar S, Gupta R, Gupta S. 2020; Role of dexmedetomidine as adjuvant in postoperative sciatic popliteal and adductor canal analgesia in trauma patients: a randomized controlled trial. Korean J Pain. 33:166–75. DOI:
10.3344/kjp.2020.33.2.166. PMID:
32235017. PMCID:
PMC7136291.
Article
3. Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, et al. 2012; Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 307:1151–60. DOI:
10.1001/jama.2012.304. PMID:
22436955.
Article
4. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. 2009; Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 301:489–99. DOI:
10.1001/jama.2009.56. PMID:
19188334.
Article
5. Gerlach AT, Dasta JF, Steinberg S, Martin LC, Cook CH. 2009; A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients. J Crit Care. 24:568–74. DOI:
10.1016/j.jcrc.2009.05.015. PMID:
19682844. PMCID:
PMC3725302.
Article
6. Klinger RY, White WD, Hale B, Habib AS, Bennett-Guerrero E. 2012; Hemodynamic impact of dexmedetomidine administration in 15,656 noncardiac surgical cases. J Clin Anesth. 24:212–20. DOI:
10.1016/j.jclinane.2011.07.016. PMID:
22484025.
Article
7. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. 2017; Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 56:893–913. DOI:
10.1007/s40262-017-0507-7. PMID:
28105598. PMCID:
PMC5511603.
Article